pharma · Becker Muscular Dystrophy · Muscular Dystrophies · EWTX
Edgewise Therapeutics
Edgewise Therapeutics trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
1715 38th St., Boulder, CO 80301, US HQ
2017 Founded
154 Employees
Public company Type
EWTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1715 38th St., Boulder, CO 80301, US
- Founded
- 2017
- Employees
- 154
- Programs
- 15
- Drugs
- 3
- Patents
- 7
Edgewise Therapeutics clinical trials
Registry index of 17 ClinicalTrials.gov studies linked to Edgewise Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Edgewise Therapeutics trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Edgewise Therapeutics.
-
Sevasemten Dose 1 — Phase 2
Clinical update -
EDG-5506, EDG-5506 — Phase 2
Clinical update -
Sevasemten — Phase 2
Clinical update -
Sevasemten 10 mg — Phase 2
Clinical update -
EDG-5506 Tablet — Phase 1
Clinical update -
EDG-5506 — Phase 1
Clinical update -
EDG-7500 — Phase 2
Clinical update -
EDG-15400 — Phase 1
Clinical update